Blog
[printfriendly]
-
Mar 1, 2012
FDA Panel Gives the Green Light for More Anti-NGF Testing
The US FDA has agreed to resume clinical trials with anti-nerve growth (NGF) drugs despite cases of side effects stating the risk-benefit profile indicated a role for their ongoing development…. -
Mar 1, 2012
Role of Calcium/Magnesium Infusion in Oxaliplatin-based Chemotherapy for Colorectal Cancer Patients
Early screening seems to be having a positive impact on the incidence of new cases of colorectal cancer over that past 2 decades. Unfortunately, the treatment of choice, Oxaliplatin, produces… -
Mar 1, 2012
St. Louis University Researcher Targets Pain in Chemotherapy
Dr. Daniela Salvemini, associate professor of pharmacolgical and physiolgical science at SLU School of Medicine has been awared a grant to research a way to help ease, or stop, pain… -
Feb 1, 2012
Spinal Cord Stimulation Effective for HIV Neuropathy
At the 6th World Congress of the World Institute of Pain in Miami Beach this month, Dr. Kenneth Candido presented a poster on the success of implanting a permanent device… -
Feb 1, 2012
Publication of Phase III Study Shows Positive Results for Diabetic Neuropathic Pain
The results of a 13-week study by Avanir Pharmaceuticals, published in the journal Pain Medicine, show efficacy and safety of AVP-923 for treatment of diabetic neuropathic pain. Currently also in… -
Feb 1, 2012
Neuropathy Patients More Likely to Receive High-cost, Low-yield Screening Instead of More Effective Tests
A new study from University of Michigan researchers found that the most efficient testing is not always done for peripheral neuropathy – especially diabetes related neuropathy. Led by Dr. Brian… -
Feb 1, 2012
EpiCept Files for AmiKet™ Fast Track Designation
EpiCept Corporation announced that it has filed for Fast Track designation for AmiKet, their new topical cream to be used in the treatment of chemotherapy-induced peripheral neuropathy. The Fast Track… -
Feb 1, 2012
Fighting Off Cancer Does Cost
In a study from the Colorado Cancer Center, results have shown that using Oxaliplatin for the treatment of colorectal cancer causes Oxaliplatin-induced neurotoxicity (OXIN). One way to avoid immediate symptoms…